The Center for Rapid Device Translation is committed to collaborating with clients to navigate effective regulatory pathways through preclinical device testing. We assist with preparing the technologies, tools and facilities for applying Good Laboratory Practice (GLP), conducting successful safety studies and achieving robust data for regulatory agency approval. We guide our clients to opening the door to early phase clinical testing in humans.

As industry innovators, our clients have access to entrepreneurs and scientists with invaluable expertise and insight during the foundational planning and first phases of product development. We offer a full suite of services, centralized in the extensive research facilities of our research institute, enabling efficient workflow without leaving Houston Methodist, located in the heart of the Texas Medical Center (TMC). The TMC is the world’s largest medical complex, boasting eight academic and research institutions and 21 hospitals serving over 7 million visitors per year.